Addex Therapeutics (ADXN) Short Interest Ratio & Short Volume → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free ADXN Stock Alerts $8.79 -0.21 (-2.33%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Addex Therapeutics Short Interest DataCurrent Short Volume14,700 sharesPrevious Short Volume21,700 sharesChange Vs. Previous Month-32.26%Dollar Volume Sold Short$112,455.00Short Interest Ratio / Days to Cover0.8Last Record DateApril 30, 2024Outstanding Shares1,060,000 sharesFloat Size793,400 sharesShort Percent of Float1.85%Today's Trading Volume8,463 sharesAverage Trading Volume17,809 sharesToday's Volume Vs. Average48% Short Selling Addex Therapeutics ? Sign up to receive the latest short interest report for Addex Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADXN Short Interest Over TimeADXN Days to Cover Over TimeADXN Percentage of Float Shorted Over Time Ad Crypto 101 Media“Dollar Will Be Worth NOTHING” -MuskElon Musk just issued an urgent warning… Saying “The U.S. Dollar will be worth NOTHING…” As "stealth money printing" pushes the price of Bitcoin, Ethereum, XRP and crypto higher.Click here to claim your free seat ticket now. Addex Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202414,700 shares $112,455.00 -32.3%1.9%0.8 $7.65 4/15/202421,700 shares $537,075.00 +149.4%2.7%1.3 $24.75 3/31/20248,700 shares $111,360.00 -26.9%0.9%0.5 $12.80 3/15/202411,900 shares $139,349.00 +41.7%1.2%1.2 $11.71 2/29/20248,400 shares $79,884.00 +33.3%0.8%0.9 $9.51 2/15/20246,300 shares $66,087.00 -27.6%0.6%0.7 $10.49 Get the Latest News and Ratings for ADXN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Addex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20248,700 shares $94,308.00 +222.2%0.9%0.8 $10.84 1/15/20242,700 shares $18,765.00 +12.5%0.3%0.3 $6.95 12/31/20232,400 shares $14,520.00 -33.3%0.2%0.2 $6.05 12/15/20233,600 shares $19,548.00 -14.3%0.4%0.4 $5.43 11/30/20234,200 shares $23,310.00 -25.0%0.5%0.5 $5.55 11/15/20235,600 shares $34,160.00 +5.7%0.8%0.8 $6.10 10/31/20235,300 shares $33,337.00 No Change0.8%1 $6.29 10/15/20235,300 shares $43,036.00 -95.4%N/A1.3 $8.12 9/30/2023115,900 shares $44,540.37 -35.0%N/A1.7 $0.38 9/15/2023178,200 shares $74,844.00 +76.1%N/A3.3 $0.42 8/31/2023101,200 shares $46,248.40 -8.9%N/A2 $0.46 8/15/2023111,100 shares $59,216.30 -4.4%N/A1.7 $0.53 7/31/2023116,200 shares $65,072.00 -16.6%N/A0.3 $0.56 7/15/2023139,400 shares $82,106.60 -13.6%N/A0.4 $0.59 6/30/2023161,300 shares $84,037.30 -28.7%N/A0.4 $0.52 6/15/2023226,300 shares $149,358.00 -40.4%3.0%0.5 $0.66 5/31/2023379,900 shares $246,593.09 -43.6%5.1%0.7 $0.65 5/15/2023673,100 shares $567,086.75 +358.5%9.0%1.2 $0.84 4/30/2023146,800 shares $104,183.96 -34.2%N/A0.4 $0.71 4/15/2023223,100 shares $172,980.59 +195.9%N/A0.5 $0.78 3/31/202375,400 shares $71,343.48 -7.6%N/A0.2 $0.95 3/15/202381,600 shares $89,760.00 -75.9%N/A0.3 $1.10 2/28/2023338,700 shares $694,335.00 +149.8%N/A1.1 $2.05 2/15/2023135,600 shares $203,400.00 -55.2%N/A0.5 $1.50 1/31/2023302,400 shares $323,568.00 +484.9%N/A1.3 $1.07 1/15/202351,700 shares $44,979.00 +28.0%N/A0.3 $0.87 12/30/202240,400 shares $25,456.08 +15.8%0.5%0.3 $0.63 12/15/202234,900 shares $21,149.40 -25.3%0.9%0.3 $0.61 11/30/202246,700 shares $35,954.33 -57.4%1.6%0.3 $0.77 11/15/2022109,700 shares $89,416.47 +247.2%3.6%0.7 $0.82 10/31/202231,600 shares $26,860.00 -41.6%0.6%0.2 $0.85 10/15/202254,100 shares $43,280.00 -43.1%0.9%0.2 $0.80 9/30/202295,100 shares $76,060.98 +37.0%1.7%0 $0.80 9/15/202269,400 shares $66,624.00 -46.7%1.2%0 $0.96Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.Click here if you’d like to learn more about these five cryptos… ADXN Short Interest - Frequently Asked Questions What is Addex Therapeutics' current short interest? Short interest is the volume of Addex Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 14,700 shares of ADXN short. 1.85% of Addex Therapeutics' shares are currently sold short. Learn More on Addex Therapeutics' current short interest. What is a good short interest ratio for Addex Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADXN shares currently have a short interest ratio of 1.0. Learn More on Addex Therapeutics's short interest ratio. What is a good short interest percentage for Addex Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.85% of Addex Therapeutics' floating shares are currently sold short. Is Addex Therapeutics' short interest increasing or decreasing? Addex Therapeutics saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 14,700 shares, a drop of 32.3% from the previous total of 21,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Addex Therapeutics' float size? Addex Therapeutics currently has issued a total of 1,060,000 shares. Some of Addex Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Addex Therapeutics currently has a public float of 793,400 shares. How does Addex Therapeutics' short interest compare to its competitors? 1.85% of Addex Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Addex Therapeutics: Aeterna Zentaris Inc. (0.34%), NuCana plc (1.21%), Alterity Therapeutics Limited (1.03%), Molecular Templates, Inc. (4.68%), Chemomab Therapeutics Ltd. (0.98%), Galera Therapeutics, Inc. (7.34%), Guardion Health Sciences, Inc. (14.33%), Moleculin Biotech, Inc. (1.45%), MIRA Pharmaceuticals, Inc. (0.42%), Avalo Therapeutics, Inc. (10.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Addex Therapeutics stock? Short selling ADXN is an investing strategy that aims to generate trading profit from Addex Therapeutics as its price is falling. ADXN shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Addex Therapeutics? A short squeeze for Addex Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADXN, which in turn drives the price of the stock up even further. How often is Addex Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADXN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: AEZS Short Interest Data NCNA Short Interest Data ATHE Short Interest Data MTEM Short Interest Data CMMB Short Interest Data GRTX Short Interest Data GHSI Short Interest Data MBRX Short Interest Data MIRA Short Interest Data AVTX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADXN) was last updated on 5/17/2024 by MarketBeat.com Staff From Our Partners348 million Americans lives to END as we know it?The Oxford ClubCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceGold Set to EXPLODE!Gold Safe ExchangeInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsHow Biden has already won 2024Porter & CompanyA once-in-a-century investment opportunityStansberry ResearchCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm Press